Comprehensive Development Services Oakwood Labs offers end-to-end support for long-acting injectable development, encompassing formulation, scale-up, and GMP manufacturing, presenting opportunities to collaborate across various stages of pharmaceutical product development.

Innovation in Sustained Release Technology With proprietary microsphere technology tailored for specific release profiles, Oakwood Labs is positioned to meet client needs for customized drug delivery solutions, making it a strategic partner for companies seeking advanced injectable formulations.

Strategic Partnerships Oakwood's recent collaborations with industry players like Edge Therapeutics highlight its capability to support commercial manufacturing and product launch activities, opening avenues for new contract manufacturing and supply agreements.

Financial Stability Generating revenue between 50 million and 100 million dollars, Oakwood Labs has a solid financial foundation that supports expansion efforts and investment in innovative technologies, appealing to potential partners looking for reliable manufacturing partners.

Market Positioning Situated in the competitive pharmaceutical manufacturing sector with innovative technology offerings, Oakwood Labs can leverage its focused expertise to target biotech and pharmaceutical companies seeking specialized long-acting injectable solutions.